MindWalk Holdings HYFT
NASDAQ HYFT
$1.32 -0.01 (-0.75%)
As of: Sep 4, 2026 · 11:47 AM EDT

MindWalk Holdings (HYFT) EBITDA (2020 - 2026)

MindWalk Holdings (HYFT) posted quarterly EBITDA of -$2.3 billion for Q2 2026, down 95.61% year-over-year from -$53.0 billion in Q2 2025, and down 12999563.61% quarter-over-quarter from -$17912.6 in Q1 2026.

Analysis

MindWalk Holdings (HYFT) EBITDA (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported EBITDA for 7 consecutive years, with -$2.3 billion the latest figure, recorded in Q2 2026.

  • In Q2 2026, EBITDA fell 95.61% year-over-year to -$2.3 billion; the TTM figure through Apr 2026 stood at -$2.3 billion (up 50.96% YoY), while the FY2026 annual figure was -$2.3 billion, up 42.98% from the prior year.
  • EBITDA declined to -$2.3 billion in Q2 2026 per HYFT's latest filing, from -$17912.6 in the prior quarter.
  • Across five years, EBITDA topped out at $16.6 million in Q2 2023 and bottomed at -$3.6 billion in Q3 2024.
  • Historically, EBITDA has averaged -$394.0 million across 5 years, with a median of -$1.0 million in 2025.
  • Annual changes were most pronounced in 2023 — EBITDA surged 590.74% — and 2024, when it slumped 117339930.13%.
  • MindWalk Holdings' EBITDA stood at -$5.89 in 2022, then slumped by 35218.16% to -$2080.5 in 2023, then plunged by 142593.62% to -$3.0 million in 2024, then surged by 32.62% to -$2.0 million in 2025, then sank by 116303.6% to -$2.3 billion in 2026.
  • Business Quant data shows HYFT's EBITDA at -$2.3 billion in Q2 2026, -$17912.6 in Q1 2026, and -$2.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn 493.00 Mn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -505.13 Mn
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn - 133.12 Mn
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn -1.55 Mn
10 MindWalk Holdings 61.22 Mn 52.95 Mn 1.82 Mn -2.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -2.33 Mn
Jan 31, 2026 -2.65 Mn
Oct 31, 2025 -2.00 Mn
Jul 31, 2025 -3.03 Mn
Apr 30, 2025 -1.19 Mn
Jan 31, 2025 -17.51 Mn
Oct 31, 2024 -2.97 Mn
Jul 31, 2024 -3.56 Bn
Apr 30, 2024 -16.47 Mn
Jan 31, 2024 -2.47 Mn
Oct 31, 2023 -4.26 Bn
Jul 31, 2023 -5.13 Bn
Apr 30, 2023 -4.49 Mn
Jan 31, 2023 -3.40 Mn
Oct 31, 2022 -5.89 Mn
Jul 31, 2022 -7.81 Mn
Apr 30, 2022 -3.38 Mn
Jan 31, 2022 -2.63 Mn
Oct 31, 2021 -3.56 Mn
Jul 31, 2021 -2.82 Mn